Medication assessment is often absent from falls assessment and reassessment. As a result, patients who are at risk for falls may receive medications that increase falls risk. In 2006, more than 4,000 of the total 33,882 falls reported to PA-PSRS were associated with concomitant use of two or more medications. Seventy percent (23,806) of the falls did not result in any patient harm, and less than 1% (17) indicated deaths associated with falls. Medication classes contributing to fall risk that were most frequently reported to PA-PSRS include anxiolytics/hypnotics, antidepressants, neuroleptics, opioid analgesics/antagonists, and insulin/oral hypoglycemics. Risk reduction strategies include recognizing the problem and involving pharmacy staff in developing medication assessment and reassessment strategies for patients at risk for falls.
* Correction (Pa Patient Saf Advis 2008 Jun;6:38.)
[An elderly] patient had been assessed at 7 a.m.; [the patient was] in bed, [there were] no unusual findings, and four side rails were up as per order. At approximately 7:30 a.m., a nurses aide went into the room and found the patient on floor, unresponsive. No carotid pulse was noted. Resuscitation was initiated, but unsuccessful. . . . The patient had been prescribed benzodiazepines, anticoagulants, laxatives, diuretics, and antipsychotic medications.
Medications may have compounding effects that increase the potential for falls or the potential for harm from falls. Although most healthcare professionals consider patients’ falls risk, medications may be prescribed and dispensed without proper consideration of patient selection, contraindications, or drug-drug interactions for patients who are at high risk for falls. Some PA-PSRS reports, such as the one above, discuss patients who were taking medications that could have factored into the falls or the falls outcomes. Other reports did not indicate initial medication high-risk falls assessments, or made it clear that patients were not subject to medication re-evaluations after falling.
Over the course of one year (2006), 33,882 falls events associated with medications were reported to PA-PSRS. Of these, the severity of effect was reported as no injury in 70% of falls (23,806). (See Table 1.) The most common injury as a result of falls required the application of ice, dressings, and limb elevation. There were, however, reports of severe injuries that required sutures, splints, fractures, and surgery. Less than 1% (17 reports) indicated death as the result of falls.
Number of Falls
Required dressing, ice, cleaning, limb elevation, or topical medication
Resulted in suturing, steri-strips, fracture or splinting
Resulted in surgery, casting, or traction
Patient died as a result of fall
The Joint Commission requires organizations to implement and evaluate the effectiveness of a falls reduction program.1 The falls reduction program should include an evaluation of falls history and medication review. A literature review revealed that many healthcare facilities include pharmacy review of medications
only after a patient falls or is identified as at high risk for falling.2 A review of the 2006 PA-PSRS reports of falls associated with medications indicated that there was a concomitant use of two or more medications in more than 4,000 instances. This concomitant use may have contributed to patients’ falls risk (see Table 2), although most of these reports indicated that the medications prescribed for the patients did not or were not known to contribute to the patient falls. A medication review by pharmacists can assist to identify and notify prescribers of medications that require adjustment. If possible, this review is conducted during the initial falls assessment, but there should also be a stopgap measure during prescription order fulfillment in which newly ordered medications are reviewed to determine if there will be an increase in falls risk. Including a pharmacist is important because many falls are the result of dosage issues, drug-drug interactions, or other problems related to medications. Further, the pharmacist is an integral part of the healthcare team for patient safety. Certain drugs may have exacerbating effects that contribute to patient falls. The dosage adjustment and discontinuation of these medications can lower the potential for a patient fall.3
Number ofMedications Listed
2006 PA-PSRS FallsReports
Medications Contributing to Falls Risk
Commonly prescribed medications, including antidepressants, anxiolytics/hypnotics, and insulin and oral hypoglycemics, increase the risk of falling by causing changes in cognitive and physical function, dizziness or lightheadedness, balance difficulties, confusion, and sedation.2 Ongoing pharmacy review of patients’ medications can identify potential interactions and side effects that may increase falls risk, and when possible, identify opportunities to reduce the dose of medications, discontinue medications, or select alternatives. Reducing the number and types of medications, particularly antidepressants and anxiolytics/hypnotics, can be an effective falls prevention strategy when used alone or as part of a multicomponent intervention.2 In 2006, the medication classes associated with falls that were most frequently reported to PA-PSRS included anxiolytics/hypnotics, antidepressants, neuroleptics, opioid analgesics/antagonists, and insulin/oral hypoglycemics (see “Medication Classes Most Commonly Reported with Falls in PA-PSRS”).
Routine medication assessment and reassessment as part of identifying a patient’s falls risk is important when interventions are implemented to prevent patient falls, yet according to Perell et al., not all available falls assessment tools consider these measures necessary to evaluate fall risk.4
Of the 33,882 drug-associated falls reports submitted to PA-PSRS in 2006, falls assessments identified 55% of the patients at high risk for falls, while 22% of the patients who fell had not received falls risk assessments at all. (See Table 3.)
2006 PA-PSRS Reports Indicate High Falls Risk Assessment
Information not specified or unknown
The following PA-PSRS report outlines the need for routine medication assessment and reassessment in falls prevention.
A 66-year-old patient was found on the bathroom floor. He sustained a subdural hematoma that required surgical intervention. He had been prescribed cardiac/antihypertensive medication prior to the fall but had not been considered high risk for falls.
Medications may be prescribed, dispensed, and administered without proper consideration of patient selection criteria, contraindications, and drug-drug interactions for patients who are identified at high risk for falls. The inclusion of pharmacy staff can provide ongoing medication assessment and reassessment during the development of the falls prevention program and medication reconciliation, as well as when filling a prescription order.
Risk Reduction Strategies
Healthcare facilities may consider the following information when developing medication assessment and reassessment strategies to reduce falls risk.
Routine Assessment, Reassessment, and Reconciliation of Routine Medications
When medications are routinely assessed and reassessed in patients with falls risk, their use will be minimized whenever possible. Healthcare facilities may consider involving pharmacy staff during the development or revision of interdisciplinary falls prevention programs to address medication assessment and reassessment strategies. Pharmacist involvement assists prescribers in determining whether a lower dose of a medication or an alternate drug has less falls risk potential, considering laboratory test results (i.e., renal and hepatic function) and side effects. Further, pharmacists can assist prescribers with medication selection for patients known to be at high risk for falls. Pharmacists also review medications for increased falls risk when prescriptions orders are being filled. If providers are not knowledgeable about the contraindications for patients at high risk for falls, then the pharmacy staff may provide information to prescribers about which medications have fewer side effects.
Routine Assessment and Reassessment with Medications that Increase Fall Risk
Consider providing falls risk assessments for those patients taking certain medications that increase falls risk or harm. Involving pharmacy staff also supports prescribers and nurses in the medication reconciliation process, including assessment of medications, over-the-counter drugs, and herbal supplements. Whenever feasible, organizations could consider the use of a 24-hour pharmacy service so prescribers and nurses have access to ongoing pharmacy consultation and medication reconciliation services.5 Hospitals may consider creating a list of high-risk medications currently in the hospital formulary and make it available to nurses, physicians, and pharmacists. These medications should be noted as high risk within computerized order entry systems.
Reviewing all falls prevention strategies, including medications, is necessary before and after the patient falls so that realistic and appropriate changes can be made to help minimize the risk of falls. Without ongoing physician, nursing, and pharmacy involvement in the falls prevention and medication assessment and reassessment processes, failure to identify and implement necessary modifications will result in more falls because of medications. Falls prevention strategies should have a medication component associated with pharmacy review as part of a falls prevention program.6
- Joint Commission. FAQs for the 2007 National Patient Safety Goals [online]. 2007 Jan [cited 2007 Nov 12]. Available from Internet:
- Oliver D, Daly F, Martin FC, et al. Risk factors and risk assessment tools for falls in hospital in-patients: a systematic review.
Age Ageing 2004 Mar;33(2):122-30.
- Centers for Disease Control and Prevention, The Merck Company Foundation. The state of aging and health in America [report online]. 2007 [cited 2007 Nov 12]. Available from Internet:
- Perell K, Nelson A, Goldman RL, et al. Fall risk assessment measures: an analytic review.
J Gerontol A Biol Sci Med Sci 2001 Dec;56(12):M761-6.
- ECRI Institute. Medication safety.
Healthcare Risk Control 2007 Nov;4: Pharmacy and medications 1:1-31.
- Assessment of risk and use of interventions. Chapter 3. In: ECRI Institute.
Falls prevention: strategies in healthcare settings. Plymouth Meeting (PA) ECRI Institute; 2006.
Medication Classes Most Commonly Reported with Falls in PA-PSRS
The following medication classes associated with falls were most frequently reported to PA-PSRS in 2006.
Anxiolytics/hypnotics. Benzodiazepines are the most commonly reported anxiolytic drugs. Common side effects include orthostatic hypotension, vertigo, and lethargy. Due to the onset of action of these drugs (within 30 minutes to 1 hour, with a peak action of 1 to 2 hours), unsteady gait is a significant concern, particularly with concomitant use of other medications and other disease processes.1
Antidepressants. While these medications elevate mood and improve mental alertness, one significant adverse effect is orthostatic hypotension, which increases the risk for falls and is a potentially serious problem, particularly in the elderly.1
Neuroleptics. These medications work to block dopamine and serotonin receptors and many of the newer agents are also adrenergic, cholinergic, and histamine receptor blockers. The actions of these medications cause side effects that include orthostatic hypotension, vertigo, confusion, and extrapyramidal effects.1
Opioid analgesics/antagonists. Adverse effects include respiratory depression and sedation. These effects, combined with population-specific conditions, difficulty with ambulation, and concomitant use of other medication, may increase the risk for falls.1
Insulin/oral hypoglycemics. Due to the various types of exogenous insulin and oral hypoglycemic agents, the duration of action varies from patient to patient. For exogenous insulin, the injection site and tissue condition can alter the absorption rate and peak action times. Too little or too much insulin can cause hyper- or hypoglycemic reactions, which can result in orthostatic hypotension, vertigo, and change in mental status.1
Mycek MJ, Harvey RA, Champe PC. Pharmacology, 2nd ed. Philadelphia (PA): Lippincott Williams & Wilkins; 2000.